Under BRD7 deficiency and CHK1 accumulation, the CHK1 inhibitors induced higher tumor cell apoptosis (Figs. 5B and S5B), with improved efficiency in killing tumor cells and reduced side effects. Here, BRD7 is linked to neoplasm.